- CloudMD Software & Services (CSE:DOC) is offering a free trial of its telemedicine service to North American healthcare professionals
- Demand for telemedicine and telehealth services has boomed since the outbreak of COVID-19
- The company will make the service available to 315 clinics and 3,000 healthcare professionals using Juno Electronic Medical Records software
- CloudMD’s share price is down 4 per cent, and currently trading at $0.48 per share
CloudMD Software & Services (CSE:DOC) is offering a free telemedicine service trial to North American healthcare professionals to help tackle COVID-19.
Since the outbreak of the new coronavirus strain, demand for telemedicine and telehealth services has reached an all-time high.
More people are accessing their healthcare providers through remote video chats, messaging, and other services, to reduce infection risks.
CloudMD’s Chief Medical Officer, Dr David Ostrow, said the company has offered support to health agencies and all government levels.
“We are focused on mitigating the stressors placed on the public healthcare system by providing patients access to the care they need, while reducing the burden on emergency rooms and walk-in clinics,” he said.
The CDC and President Trump both recently declared that telemedicine and telehealth has a vital role in the fight against the pandemic.
On Friday, President Trump announced that his administration would waive certain federal rules, allowing more doctors to provide care remotely. The US House of Representatives also passed a coronavirus relief bill, with a provision that may help Medicare beneficiaries access virtual healthcare.
In Canada, the Ministry of Health is working to provide more telehealth resources in order to meet growing demand. An emergency telemedicine code is now available to Ontario patients, who can be billed through the province’s medical payment plan, Ontario Health Insurance Plan.
The Canadian Medical Protective Association announced that it will cover any Canadian physician seeing any Canadian patients during the crisis.
CloudMD CEO, Dr Essam Hamza, reported a tremendous increase in interest in telemedicine solutions and services in recent weeks.
“It is vital that healthcare professionals continue servicing their patients during this crisis. Telemedicine allows for an efficient and safe way to triage patients while protecting them and others from spreading the coronavirus,” he said.
CloudMD will immediately make its integrated telemedicine service available (on a free-trial basis) to 315 clinics and 3000 healthcare professionals. The company will do so through its Juno Electronic Medical Records software.
Physicians within the system will be able to schedule and access all appointments directly through the app. People can initiate telemedicine visits with a single click, and no need for different interfaces.
CloudMD’s share price is down 4 per cent, and is currently trading at C$0.48 per share, as of 12:49pm EST.